Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

Published on by Environmental Scientists

Dr. Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

PhD candidate, Institute of drug discovery and development, Zhengzhou University, China

Nigatu Tadesse Gebrehiwot is a dedicated clinical pharmacist and PhD candidate in Pharmacology at Zhengzhou University, China 🇨🇳. With a strong background in drug safety, cancer care, and clinical trials, he combines research, patient-centered care, and academic writing to advance pharmaceutical sciences. Fluent in English (CEFR: C2) and well-versed in pharmacotherapy, Nigatu is recognized for his interdisciplinary expertise and contributions to national and international healthcare initiatives 🌐💊.

Profile

Orcid

🎓 Education

Nigatu earned his Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University 🇨🇳 (2016–2019), where he was honored for presenting research at the ISPOR European Congress in Barcelona. He completed his Bachelor of Pharmacy at Mekelle University 🇪🇹 (2009–2014), where he was celebrated as the most outstanding student. His academic journey reflects consistent excellence and passion for clinical research and therapeutic outcomes 📚🏅.

🧪 Experience

Nigatu has held various impactful roles in healthcare and pharmaceutical research. As Principal Scientific Officer at Ethiopia’s Ministry of Health 🇪🇹, he led disease management and national drug therapy protocols. He also served as Technical Manager at CBC Pharmacy, oversaw clinical pharmacy at Teklehaiymanot Hospital, and advised over 50 drug access projects for the Chinese market 🌍. Currently, he is pursuing a PhD in Pharmacology at Zhengzhou University, specializing in drug safety and clinical outcomes 🔬🩺.

🔬 Research Interest

Nigatu’s research interests span methionine metabolism in cancer, therapeutic drug evaluation, clinical trial outcomes, and antimicrobial therapy. He is particularly focused on immunotherapy, functional disease outcome measures, and innovative diagnostic methods. His goal is to improve patient care through translational and evidence-based pharmaceutical research 💡🧬.

🏆 Awards

Nigatu received an award for his research abstract at the 21st European Congress ISPOR in Barcelona, Spain 🇪🇸. He’s been acknowledged nationally and internationally for his scientific contributions and health policy initiatives. His ongoing membership in global societies like ISPOR, ISOPP, and ESMO underlines his excellence in pharmacology and healthcare outcome research 🥇🌍.

📚 Publications

Molecular Alterations in Gastric Intestinal Metaplasia (2025) – Biomedicines, 13(4):964
🔗 Read Article

Folate Species Analysis Challenges – Under revision in Bioanalysis

Methionine Metabolism in Immunotherapy – Under review in Novel Practice in Medical Study

Dioscorea zingiberensis Overview (2018) – Journal of Ethnopharmacology
🔗 Read Article

Toxicity of Dioscorea Extracts in Dogs (2017) – Regulatory Toxicology and Pharmacology
🔗 Read Article

Amide Alkaloid Synthesis and Anticancer Activity (2017) – Journal of Natural Product Research
🔗 Read Article

Wastewater Treatment in Diosgenin Production (2018) – Journal of Cleaner Production
🔗 Read Article

Antibiotic Prescribing in Sierra Leone – Royal Society of Tropical Medicine and Hygiene
🔗 Read Article

Self-Medication in Addis Ababa – Expert Review of Anti-infective Therapy
🔗 Read Article

Survival Time in HIV/TB Co-infection – Value in Health
🔗 Read Article

📝 Conclusion

Mr. Nigatu Tadesse Gebrehiwot presents a strong and well-rounded profile suitable for the Best Researcher Award, especially within clinical pharmacology, health outcomes research, and drug safety. His multidisciplinary expertise, global engagement, and impactful publications showcase his excellence. With continued leadership in original research and enhanced visibility as principal investigator, he can solidify his position among the top-tier researchers internationally.

Pruteanu Lavinia-Lorena | Natural therapeutics | Best Researcher Award

Published on by Environmental Scientists

Assist. Prof. Dr Pruteanu Lavinia-Lorena | Natural therapeutics | Best Researcher Award

Assistant professor, UTCN, Romania 

Dr. Lavinia-Lorena Pruteanu is an Assistant Professor at the Department of Chemistry and Biology, UTCN Cluj-Napoca, Romania. She specializes in health sciences, biomedical sciences, medicinal biochemistry, and nutrition. With a career spanning academia and research, Dr. Pruteanu has a strong focus on pharmaceutical sciences, drug discovery, and the application of bioinformatics in cancer research. She is a dedicated educator and mentor, supervising both bachelor’s and master’s students. Additionally, she has been involved in various international research projects, particularly in the fields of transcriptomics, natural products, and glioblastoma treatments. Her research contributions have been recognized globally.

Profile

Google Scholar

Education

Dr. Pruteanu holds a doctoral degree (Summa Cum Laude) in Chemistry with applications in biomedical life sciences, specializing in cheminformatics and bioinformatics. She also completed a Master’s degree in Clinical Chemistry and holds another Master’s degree in Nutrition and Quality of Life. She obtained her Bachelor’s degree in Biochemistry and Nutrition and Dietetics from the University of Cluj-Napoca and the University of Medicine and Pharmacy Cluj-Napoca.

Experience

Dr. Pruteanu has held multiple prominent research roles, including Senior Scientist at IOTA Pharmaceuticals (Cambridge, UK), where she led gene expression research on glioblastoma and cancer cell lines. As a postdoctoral researcher at IOTA Pharmaceuticals and the University of Cambridge, she worked on the development of drug banks and the analysis of gene expression data for drug discovery. Additionally, she has served as a visiting researcher at prestigious institutions such as King’s College London and the University of Lincoln. Her academic experience includes teaching health sciences and biomedical sciences at UTCN Cluj-Napoca, where she also supervises graduate and undergraduate research.

Research Interests

Dr. Pruteanu’s research interests span across pharmaceutical sciences, natural products, drug discovery, bioinformatics, and transcriptomics. She focuses on understanding the molecular mechanisms of cancer treatments, particularly glioblastoma, and the effects of synthetic and natural products on gene expression in cancer cells. Her work also includes using data-driven approaches to discover novel therapeutic agents and examining the role of bioinformatics in the pharmaceutical and biomedical fields.

Awards

Dr. Pruteanu has received several prestigious awards, including the World Federation of Scientists Scholarship for her work on anti-inflammatory herbal actions. She was also a finalist in the “Student of the Year in Romania” competition (2015-2016) and received the Erasmus Scholarship for a research visit to the University of Cambridge. Furthermore, she has been recognized for her contributions to doctoral research mobility, including the POSDRU fellowship and the World Federation of Scientists Fellowship.

Publications Top Notes

Dr. Pruteanu has published numerous research articles in high-impact journals, contributing to the advancement of drug discovery and cancer research. Notable publications include:

Pruteanu L., et al. (2023) “Transcriptomic-based drug repurposing for glioblastoma treatment,” Cancer Research, DOI:10.1016/j.cancerres.2023.04.005, Cited by 24.

Pruteanu L., et al. (2022) “Fucoxanthin as a potential natural compound for cancer therapy,” Phytochemistry Reviews, DOI:10.1007/s11101-022-09723-9, Cited by 12.

Conclusion

 Dr. Pruteanu’s impressive track record in biomedical research, her leadership in significant scientific projects, and her continued commitment to advancing knowledge in the fields of drug discovery and cancer research make her a worthy candidate for the “Best Researcher” award. Her ability to work in diverse, high-impact academic settings, combined with her contributions to both applied and theoretical research, underscores her exceptional potential as a researcher and a leader in the scientific community. With continued focus on translating her research into broader applications, Dr. Pruteanu has the opportunity to make even more groundbreaking contributions to the field.